Inhibitors of Human Protein Kinase CK2
Journal of Medicinal Chemistry, 2006, Vol. 49, No. 22 6449
(2) Pinna, L. Protein Kinase CK2. Int. J. Biochem. Cell. Biol. 1997, 29,
551-554.
(3) Niefind, K.; Guerra, B.; Ermakowa, I.; Issinger, O. G. Crystal
Structure of Human Protein Kinase CK2: Insights into Basic
Properties of the CK2 Holoenzyme. EMBO J. 2001, 20, 19, 5320-
5331.
(24) Meggio, F.; Pinna, L. A.; Marchiori, F.; Borin, G. Polyglutamyl
Peptides: A New Class of Inhibitors of Type-2 Casein Kinases. FEBS
Lett. 1983, 162, 235-238.
(25) Tellez, R.; Gatica, M.; Allende, C. C.; Allende, J. E. Copolymers of
Glutamic Acid and Tyrosine Are Potent Inhibitors of Oocyte Casein
Kinase II. FEBS Lett. 1990, 265, 113-116.
(4) Tuazon, P. T.; Traugh, J. A. Casein kinase I and II. Multipotential
Serine Protein Kinases: Structure, Function and Regulation. In
AdVances in Second Messenger and Phosphoprotein Research;
Greengard, P., Robison, G. A., Eds; Raven Press: Ltd.: New York,
1991; Vol. 23, pp 123-164.
(5) Lindberg, R. A.; Quinn, A. M.; Hunter, T. Dual-Specificity Protein
Kinases: Will Any Hydroxyl Do? Trends Biochem. Sci 1992, 17,
114-119.
(6) Wilson, L. K.; Dhillon, N.; Thorner, J.; Martin, G. S. Casein Kinase
II Catalyzes Tyrosine Phosphorylation of the Yeast Nucleolar
Immunophilin Fpr3. J. Biol. Chem. 1997, 272, 12961-12967.
(7) Unger, G. M.; Davis, A. T.; Slaton, J. W.; Ahmed, K. Protein Kinase
CK2 as Regulator of Cell Survival: Implications for Cancer Therapy.
Curr. Cancer Drug Targets 2004, 4, 77-84.
(8) Kelliher, M. A.; Seldin, D. C.; Leder, P. Tal-1 Induces T Cell Acute
Lymphoblastic Leukemia Accelerated by Casein Kinase Iialpha.
EMBO J. 1996, 15, 5160-5166.
(26) Hathaway, G. M.; Lubben, T. H.; Traugh, J. A. Inhibition of Casein
Kinase II by Heparin. J. Biol. Chem. 1980, 255, 8038-8041.
(27) Battistutta, R.; Sarno, S.; De Moliner, E.; Papinutto, E.; Zanotti, G.;
Pinna, L. A. The Replacement of ATP by the Competitive Inhibitor
Emodin Induces Conformational Modifications in the Catalytic Site
of Protein Kinase CK2. J. Biol. Chem. 2000, 275, 29618-
29622.
(28) Vangrevelinghe, E.; Zimmermann, K.; Schoepfer, J.; Portmann, R.;
Fabbro, D.; Furet, P. Discovery of a Potent and Selective Protein
Kinase CK2 Inhibitor by High-Throughput Docking. J. Med. Chem.
2003, 46, 2656-2662.
(29) Sarno, S.; De Moliner, E.; Ruzzene, M.; Pagano, M. A.; Battistutta,
R.; Bain, J.; Fabbro, D.; Schoepfer, J.; Elliott, M.; Furet, P.; Meggio,
F.; Zanotti, G.; Pinna, L. A. Biochemical and Three-Dimensional-
Structural Study of the Specific Inhibition of Protein Kinase CK2
by [5-Oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Biochem. J. 2003, 374, 639-646.
(9) Orlandini, M.; Semplici, F.; Ferruzzi, R.; Meggio, F.; Pinna, L. A.;
Oliviero, S. Protein Kinase CK2alpha′ Is Induced by Serum as a
Delayed Early Gene and Cooperates with Ha-ras in Fibroblast
Transformation. J. Biol. Chem. 1998, 273, 21291-21297.
(10) Landesman-Bollag, E.; Channavajhala, P. L.; Cardiff, R. D.; Seldin,
D. C. p35 Deficiency and Misexpression of Protein Kinase CK2a
Collaborate in the Development of Thymic Lymphomas in Mice.
Oncogene 1998, 23, 2965-2974.
(11) Pinna, L. A.; Meggio, F. Protein Kinase CK2 (“casein kinase-2”)
and Its Implication in Cell Division and Proliferation. Prog. Cell
Cycle Res. 1997, 3, 77-97.
(12) Ravi, R.; Bedi, A. Sensitization of Tumor Cells to Apo2 Ligand/
TRAIL-Induced Apoptosis by Inhibition of Casein Kinase II. Cancer
Res. 2002, 62, 4180-4185.
(13) Sarno, S.; Reddy, H.; Meggio, F.; Ruzzene, M.; Davies, S. P.;
Donella-Deana, A.; Shugar, D.; Pinna, L. Selectivity of 4,5,6,7-
Tetrabromobenzotriazole, an ATP Site-Directed Inhibitor of Protein
Kinase CK2 (“casein kinase”). FEBS Lett. 2001, 496, 44-48.
(14) Battistutta, R.; De Moliner, E.; Sarno, S.; Zanotti, G.; Pinna, L. A.
Structural Features Underlying Selective Inhibition of Protein Kinase
CK2 by ATP-Site Directed Tetrabromo-benzotriazole. Protein Sci.
2001, 10, 2200-2206.
(15) Szyszka, R.; Grankowski, N.; Felczak, K.; Shugar, D. Halogenated
Benzimidazoles and Benzotriazoles as Selective Inhibitors of Protein
Kinases CK I and CK II from Saccharomyces cereVisiae and Other
Sources. Biochem. Bioophys. Res. Commun. 1995, 208, 418-424.
(16) Sarno, S.; Moro, S.; Meggio, F.; Zagotto, G.; Dal Ben, D.; Ghisellini,
P.; Battistuta, R.; Zanotti, G.; Pinna, L. Toward the Rational Design
of Protein Kinase Casein Kinase-2 Inhibitors. Pharmacol. Ther. 2002,
93, 159-168.
(17) Davies, S. P.; Reddy, H.; Caivano, M.; Cohen, P. Specificity and
Mechanism of Action of Some Commonly Used Protein Kinase
Inhibitors. Biochem. J. 2000, 351, 95-10.
(18) Prykhod’ko, A. O.; Yakovenko, O. Ya.; Golub, A. G.; Bdzhola, V.
G.; Yarmoluk, S. M. Evaluation of 4H-4-Chromenone Derivatives
as Inhibitors of Protein Kinase CK2. Biopolym. Cell 2005, 21, 2,
1-6.
(19) Yim, H.; Lee, Yh.; Lee, S. K. Emodin, an Anthraquinone Derivative
Isolated from the Rhizomes of Rheum palmatum Selectively Inhibits
the Activity of Casein Kinase II as Competitive Inhibitor. Planta
Med. 1999, 65, 1, 9-13.
(20) Meggio, F.; Pagano, M. A.; Moro, S.; Zagotto, G.; Ruzzene, M.;
Sarno, S.; Cozza, G.; Bain, J.; Elliott, M.; Deana, A. D.; Brunati, A.
M.; Pinna, L. A. Inhibition of Protein Kinase CK2 by Condensed
Polyphenolic Derivatives. An in Vitro and in Vivo Study. Biochem-
istry 2004, 43, 12931-12936.
(21) Liu, X. G.; Liang, N. C. Inhibitory Effect and Its Kinetic Analysis
of Tyrphostin AG1478 on Recombinant Human Protein Kinase CK2
Holoenzyme. Acta Pharmacol. Sin. 2002, 23, 6, 556-561.
(22) Sapelkin, V. M.; Golub, A. G.; Yakovenko, O. Ya.; Bdzhola, V. G.;
Yarmoluk, S. M. Search for Protein Kinase CK2 Inhibitors among
4-Aminoquinazoline Derivatives. Ukr. Bioorg. Acta 2004, 1, 74-79.
(23) Sapelkin, V. M.; Golub, A. G.; Yakovenko, O. Ya.; Bdzhola, V. G.;
Yarmoluk, S. M. Search for Protein Kinase CK2 Inhibitors among
3-Carboxy-4-aminoquinoline Derivatives. Ukr. Bioorg. Acta 2005,
2, 28-32.
(30) Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanan,
S. The Protein Kinase Complement of the Human Genome. Science
2002, 298, 1912-1934.
(31) Niefind, K.; Putter, M.; Guerra, B.; Issinger, O. G.; Schomburg, D.
GTP Plus Water Mimic ATP in the Active Site of Protein Linase
CK2. Nat. Struct. Biol. 1999, 6, 1100-1103.
(32) Dalhoff, A.; Shalit, I. Immunomodulatory Effects of Quinolones.
Lancet Infect. Dis. 2003, 3, 359-371.
(33) Drlica, K.; Zhao, X. DNA Gyrase, Topoisomerase IV, and the
4-Quinolones. Microbiol. Mol. Biol. ReV. 1997, 61, 377-392.
(34) Robinson, M. J.; Martin, B. A.; Gootz, T. D.; McGuirk, P. R.;
Moynihan, M.; Sutcliffe, J. A.; Osheroff, N. Effects of Quinolone
Derivatives on Eukaryotic Topoisomerase II. A Novel Mechanism
for Enhancement of Enzyme-Mediated DNA Cleavage. J. Biol. Chem.
1991, 266, 14585-14592.
(35) Traxler, P.; Green, J.; Mett, H.; Se´quin, U.; Furet, P. Use of a
Pharmacophore Model for the Design of EGFR Tyrosine Kinase
Inhibitors: Isoflavones and 3-Phenyl-4(1H)-quinolones. J. Med.
Chem. 1999, 42, 1018-1026.
(36) Wang, R.; Fu, Y.; Lai, L. A New Atom-Additive Method for
Calculating Partition Coefficients. J. Chem. Inf. Comput. Sci. 1997,
37, 615-621.
(37) Lindahl, E.; Hess, B.; van der Spoel, D. GROMACS 3.0: A Package
for Molecular Simulation and Trajectory Analysis. J. Mol. Mod. 2001,
7, 306-317.
(38) Connolly, M. L. MS: Molecular Surface Program. 1983, QCPE
Program 429, Quantum Chemistry Program Exchange, University
pchem/feature14.html.
(39) Shoichet, B. K.; Stroud, R. M.; Santi, D. V.; Kuntz, I. D.; Perry, K.
M. Structure-Based Discovery of Inhibitors of Thymidylate Synthase.
Science 1993, 259, 1445-1450.
(40) Bodian, D. L.; Yamasaki, R. B.; Buswell, R. L.; Stearns, J. F.; White,
J. M.; Kuntz, I. D. Inhibition of the Fusion-Inducing Conformational
Change of Influenza Hemagglutinin by Benzoquinones and Hydro-
quinones. Biochemistry 1993, 32, 2967-2978.
(41) Ring, C. S.; Sun, E.; McKerrow, J. H.; Lee, G. K.; Rosenthal, P. J.;
Kuntz, I. D.; Cohen, F. E. Structure-Based Inhibitor Design by Using
Protein Models for the Development of Antiparasitic Agents. Proc.
Natl. Acad. Sci. U.S.A. 1993, 90, 3583-3587.
(42) Ewing, T. J.; Makino, S.; Skillman, A. G.; Kuntz, I. D. DOCK 4.0:
Search Strategies for Automated Molecular Docking of Flexible
Molecule Databases. J. Comput. Aided Mol. Des. 2001, 15, 411-
428.
(43) Schmidt, M. W.; Baldridge, K. K.; Boatz, J. A.; Elbert, S. T.; Gordon,
M. S.; Jensen, J. H.; Koseki, S.; Matsunaga, N.; Nguyen, K. A.; Su,
S.; Windus, T. L. The General Atomic and Molecular Electronic
Structure System. J. Comput. Chem. 1993, 14, 1347-1358.
(44) Takacs-Novak, K., Noszal, B., Hermecz, I., Kereszturi, G., Podanyi
B., Szasz G. Protonation Equilibria of Quinolone Antibacterials. J.
Pharm. Sci. 1990, 79, 1023-1028.
(45) Ronald, J. R.; Scheiber, R. S. In Organic Syntheses: An Annual
Publication of Satisfactory Methods for the Preparation of Organic
Chemicals; Snyder H. R., et al., Eds.; John Wiley & Sons: New
York, 1948; Vol. 28, pp 38-41.